Regulatory Approvals

FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer

By

Regulatory Approvals — FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer  OncLive

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 21, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B

Regulatory Approvals

KACH collaboration garners FDA approval of TBI diagnosis device; device recognized by TIME

Regulatory Approvals

FDA Approves Hibsago | PharmExec

Financial News For All

Labor

California’s Largest State Employee Union Starts 1-Day Strike

Labor

Thousands of California state workers walk off job in one-day strike

Labor

Pfizer layoffs announced at Rocky Mount, Sanford facilities in NC

Labor

Big California state worker strike set to begin today